Fairbanks Capital Management, Inc. Boston Scientific Corp Transaction History

Fairbanks Capital Management, Inc.

$158 Million
Q3 2024

A detailed history of Fairbanks Capital Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Fairbanks Capital Management, Inc. holds 29,469 shares of BSX stock, worth $2.67 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

29,469

Previous 27,825 5.91%

Holding current value

$2.67 Million

Previous $2.14 Million 15.27%

% of portfolio

1.56%

Previous 1.41%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $119,946 - $138,096	1,644 Added 5.91%	29,469 $2.47 Million
Q2 2024 Aug 06, 2024	BUY	$67.33 - $77.71 $44,303 - $51,133	658 Added 2.42%	27,825 $2.14 Million
Q1 2024 May 16, 2024	SELL	$57.6 - $68.62 $24,364 - $29,026	-423 Reduced 1.53%	27,167 $1.86 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $70,430 - $83,708	1,448 Added 5.54%	27,590 $1.59 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $62,386 - $67,967	-1,243 Reduced 4.54%	26,142 $1.38 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $299,065 - $328,659	-6,015 Reduced 18.01%	27,385 $1.48 Million
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $60,691 - $67,340	-1,346 Reduced 3.87%	33,400 $1.67 Million
Q4 2022 Feb 09, 2023	SELL	$39.56 - $47.22 $4,668 - $5,571	-118 Reduced 0.34%	34,746 $1.61 Million
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $15,638 - $46,715	-426 Reduced 1.21%	34,864 $1.35 Million
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $33,125 - $44,274	-940 Reduced 2.59%	35,290 $1.32 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $736 - $811	-18 Reduced 0.05%	36,230 $1.61 Million
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $2,208 - $2,602	58 Added 0.16%	36,248 $1.54 Million
Q3 2021 Nov 10, 2021	BUY	$41.23 - $45.88 $45,888 - $51,064	1,113 Added 3.17%	36,190 $1.57 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $68,286 - $78,304	1,770 Added 5.31%	35,077 $1.5 Million
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $179,206 - $201,563	5,081 Added 18.0%	33,307 $1.29 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $327,555 - $414,705	9,881 Added 53.86%	28,226 $1.02 Million
Q2 2020 Aug 17, 2020	BUY	$30.19 - $39.11 $16,695 - $21,627	553 Added 3.11%	18,345 $729,000
Q1 2020 May 12, 2020	BUY	$25.83 - $45.71 $172,286 - $304,885	6,670 Added 59.97%	17,792 $581,000
Q4 2019 Feb 05, 2020	BUY	$37.87 - $45.37 $132,885 - $159,203	3,509 Added 46.09%	11,122 $503,000
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $306,880 - $330,784	7,613 New	7,613 $310,000

Others Institutions Holding BSX

# of Institutions

1,538

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairbanks Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fairbanks Capital Management, Inc. with notifications on news.

Account

Fairbanks Capital Management, Inc. Boston Scientific Corp Transaction History